Proangiogenic immature myeloid cells populate the human placenta and their presence correlates with placental and birthweight

American Journal of Obstetrics and Gynecology

Volumn 207, Issue 2, 2012, Pages 141.e1-141.e5

  Mei Dan, Elad ^a   Fainaru, Ofer ^a   Hantisteanu, Shay ^a   Shavit, Tal ^a   Ellenbogen, Adrian ^a   Hallak, Mordechai ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

angiogenesis; immature myeloid cells; placenta

Indexed keywords

CD33 ANTIGEN; CD45 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTICLE; BIOPSY; BIRTH WEIGHT; BONE MARROW CELL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PLACENTA; PLACENTA WEIGHT; PRIORITY JOURNAL; PROANGIOGENIC IMMATURE MYELOID CELL;

EID: 84864399442     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.05.025     Document Type: Article

References (28)

1. S.G. Holtan, D.J. Creedon, P. Haluska, S.N. Markovic Cancer and pregnancy: parallels in growth, invasion, and immnne modulation and implications for cancer therapentic agents Mayo Clin Proc 84 2009 985 1000
2. O. Fainaru, S. Hantisteanu, M. Hallak Immature myeloid cells accumulate in mouse placenta and promote angiogenesis Am J Obstet Gynecol 204 2011 544.e18 544.e23
3. + T lymphocytes in patients with advanced-stage non-small cell lung cancer J Cancer Res Clin Oncol 136 2010 35 45
4. S. Kusmartsev, D.I. Gabrilovich Role of immature myeloid cells in mechanisms of immune evasion in cancer Cancer Immunol Immunother 55 2006 237 245
5. D. Gabrilovich Mechanisms and functional significance of tumour-induced dendritic-cell defects Nat Rev Immunol 4 2004 941 952
6. D.I. Gabrilovich, M.P. Velders, E.M. Sotomayor, W.M. Kast Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells J Immunol 166 2001 5398 5406
7. S.A. Kusmartsev, Y. Li, S.H. Chen Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation J Immunol 165 2000 779 785
8. B. Almand, J.R. Resser, B. Lindman Clinical significance of defective dendritic cell differentiation in cancer Clin Cancer Res 6 2000 1755 1766
9. B. Almand, J.I. Clark, E. Nikitina Increased production of immaturemyeloid cells in cancer patients: a mechanism of immunosuppression in cancer J Immunol 166 2001 678 689
10. J. Schmielau, O.J. Finn Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of T-cell function in advanced cancer patients Cancer Res 61 2001 4756 4760
11. A.H. Zea, P.C. Rodriguez, M.B. Atkins Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion Cancer Res 65 2005 3044 3048
12. N. Mirza, M. Fishman, I. Fricke All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients Cancer Res 66 2006 9299 9307
13. P. Filipazzi, R. Valenti, V. Huber Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine J Clin Oncol 25 2007 2546 2553
14. B. Hoechst, L.A. Ormandy, M. Ballmaier A new population of myeloid-derived suppressor cell in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells Gastroenterology 135 2008 234 243
15. J.S. Ko, A.H. Zea, B.I. Rini Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients Clin Cancer Res 15 2009 2148 2157
16. O. Fainaru, H. Amsalem, Y. Bentov, N. Esfandiari, R.F. Casper CD56(bright)CD16(-) natural killer cells accumulate in ovarian follicular fluid of patients undergoing in vitro fertilization Fertil Steril 94 2010 1918 1921
17. T. Tadmor, D. Attias, A. Polliack Myeloid-derived suppressor cells - their role in haemato-oncological malignancies and other cancers and possible implications for therapy Br J Haematol 153 2011 557 567
18. C.M. Diaz-Montero, M.L. Salem, M.I. Nishimura, E. Garrett-Mayer, D.J. Cole, A.J. Montero Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy Cancer Immunol Immunother 58 2009 49 59
19. Y. Nefedova, P. Cheng, D. Gilkes Activation of dendritic cells via inhibition of Jak2/STAT3 signaling J Immunol 175 2005 4338 4346
20. N. Parrinello, P. La Cava, D. Tibullo Myeloid-derived suppressor cells in patients with Hodgkin lymphoma Blood (ASH Annual Meeting Abstracts) 114 2009 abstract 3662
21. O. Fainaru, A. Adini, O. Benny Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis FASEB J 22 2008 522 529
22. B. Webster, E.H. Ekland, L.M. Agle, S. Chyou, R. Ruggieri, T.T. Lu Regulation of lymph node vascular growth by dendritic cells J Exp Med 203 2006 1903 1913
23. C. Murdoch, M. Muthana, S.B. Coffelt, C.E. Lewis The role of myeloid cells in the promotion of tumour angiogenesis Nat Rev Cancer 8 2008 618 631
24. Y. Shaked, E.E. Voest Bone marrow derived cells in tumor angiogenesis and growth: are they the good, the bad or the evil? Biochim Biophys Acta 1796 2009 1 4
25. O. Erez, R. Romero, J. Espinoza The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age J Matern Fetal Neonatal Med 21 2008 279 287
26. F. Gotsch, R. Romero, J.P. Kusanovic Preeclampsia and small for gestational age are associated with decreased concentrations of a factor involved in angiogenesis: soluble TIE-2 J Matern Fetal Neonatal Med 21 2008 389 402
27. J. Jarvenpaa, J.T. Vuoristo, E.R. Savolainen, O. Ukkola, T. Vaskivuo, M. Ryynanen Altered expression of angiogenesis-related placental genes in preeclampsia associated with intrauterine growth restriction Gynecol Endocrinol 23 2007 351 355
28. S. Ostrand-Rosenberg Myeloid-derived suppressor cells: more mechanisms for inhibiting antitumor immunity Cancer Immunol Immunother 59 2010 1593 1600